# Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

> **NCT07475949** · PHASE3 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 352 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Tenecteplase

## Interventions

- **DRUG:** Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
- **OTHER:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07475949
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 352 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475949, "Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07475949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*